Real Estate Journal — Central New Jersey — February 10 - 23, 2017 — 7B
M id A tlantic
C entral N ew J ersey
Highlighting New Jersey’s many success stories of 2016 BioNJ Gala highlights success stories of NJ’s flourishing life sciences community
the State’s Angel Investor Tax Credit Program, had this to say about BioNJ: “Membership in BioNJ has provided us with access to tremendous resources,” Mario said. “At different stages of our development, there were different resources. Starting out, it was really network- ing, meeting people. We hired people we met through rela- tionships established at many of the meetings. And more recently we have accessed discounted chemicals and sup- plies to support our antibiotic drug development program.” n
RENTON, NJ — Rep- resentatives from the New Jersey Eco-
leadership and lobbying to develop programs and finan- cial resources that will enrich an already vibrant life sciences landscape,” BioNJ president and CEO Debbie Hart said. Member companies can take advantage of a multitude of BioNJ resources: BioNJ’s Talent Services connects entrepreneurs with capable employees who can fit their staffing needs. The service offers candidate sourc- ing, human resources exper- tise, and career coaching and training. Peer-to-peer networking and
educational events such as exclusive forums, roundtable discussions, and participation in various BioNJ commit- tees enable entrepreneurs to learn more about themselves, their community, and their industry. BioNJ also holds an annual CEO Summit, which brings together the heads of innovator companies to dis- cuss topics relevant to leaders in the life sciences sector. “New Jersey has a dynam- ic life sciences community through which emerging en- trepreneurs receive invaluable guidance from established
entities, more-seasoned inno- vators, and giants in the phar- maceutical world,” EDA CEO Melissa Orsen . “It’s through organizations like BioNJ that these relationships are culti- vated and strengthened.” TAXIS Pharmaceuticals, a Rutgers University spinout that graduated from the EDA’s Commercialization Center for Innovative Technologies, seeks to discover and develop pharmaceuticals targeting multidrug-resistant bacte- rial infections. Taxis president and CEO Greg Mario, whose company also participated in
nomic De- velopment Author i ty (EDA) joined mo r e t han 750 biotech- nology and pharmaceu- tical profes- sionals, other
government officials, academic leaders, and service providers on Feb. 2 at BioNJ’s 24th An- nual Gateway Gala & Innova- tion Celebration. Entrepreneurs from three EDA-supported companies are among those who were recognized during the gala. Celator Pharmaceuticals for- mer chief executive officer Scott Jackson, Amicus Thera- peutics chairman of the board and CEO John Crowley, and Chromocell CEO Christian Kopfli will receive BioNJ’s In- novator Award in the leader- ship category. The gala also highlighted New Jersey’s many success stories of 2016 and give trade organization BioNJ the oppor- tunity to tout why innovators choose to grow their compa- nies in New Jersey. According to BioNJ: • The Garden State boasts the world’s highest concentration of scientists and engineers per square mile – more than 225,000 statewide. • New Jersey is home to 14 of the world’s 20 largest bio- pharmaceutical companies, including Merck, Johnson & Johnson, and Pfizer, and 12 of the world’s top 22 research and development companies. • The annual economic impact of the industry in New Jersey is estimated to be $36 billion. • More than 64,210 individu- als are employed in New Jer- sey’s life sciences industry. BioNJ’s mission is to propel New Jersey’s robust life sci- ences ecosystem forward to accelerate the discovery, de- velopment and commercializa- tion of therapies and cures for the patients who need them. With more than 400 mem- ber companies, ranging from startups to large corporations, BioNJ has been an advocate for New Jersey’s life science community for over 20 years. “As New Jersey’s life scienc- es presence continues to grow, BioNJ works to advance eco- nomic development through
At Kearny Bank, we have the know-how and experience to help with your next project, no matter the size or complexity. Whether you are purchasing or refinancing, you’ll find the mortgage that is right for the future of your business. Highly competitive rates and a variety of terms are available for retail, mixed-use, commercial office, industrial, warehouse, and multi-family properties. Our in-depth knowledge of the New Jersey/New York markets is a valuable plus for many clients.
For your next project, depend on Kearny Bank… where commercial mortgages are built to your specs.
42 Banking Offices • 1-800-273-3406 • kearnybank.com
Made with FlippingBook - Online Brochure Maker